Long-term ventricular assist devices in current clinical practice

Lazar Velicki; OH Frazier

doi:10.2298/2769

Lazar Velicki Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia; Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia
OH Frazier Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, Texas, USA; Baylor College of Medicine, Houston, Texas, USA

DOI: https://doi.org/10.2298/2769

Abstract

Key words:

heart failure; heart assist device; prognosis.

References

Gaddam KK, Ventura H. Developments in heart failure 2011. Congest Heart Fail 2012; 18(2): 112−26.

Garbade J, Bittner HB, Barten MJ, Mohr FW. Current trends in implantable left ventricular assist devices. Cardiol Res Pract 2011; 2011: 290561.

Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345(20): 1435−43.

Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003; 108(25): 3059−63.

Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008. J Heart Lung Transplant 2008; 27(9): 943−56.

Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995; 222(3): 327−36; discussion 336−8.

Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricularassist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122(6): 1186−95.

Vural KM. Ventricular assist device applications. Anadolu Kardiyol Derg 2008; 8(Suppl 2): 117−30.

Moazami N, Feldman D. Rethinking the terminology of mechanical circulatory support. J Thorac Cardiovasc Surg 2012; 144(1): 2−3.

Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, et al. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 2011; 75(1): 121−8.

Frazier OH, Delgado RM. Mechanical circulatory support for advanced heart failure: where does it stand in 2003? Circulation 2003; 108(25): 3064−8.

Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009; 28(1): 44−50.

Neragi-Miandoab S. A ventricular assist device as a bridge to recovery, decision making, or transplantation in patients with advanced cardiac failure. Surg Today 2012; 42(10): 917−26.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation. Int J Technol Assess Health Care 2007; 23(2): 261−8.

Hall, CW, Liotta D, Henly WS, Crawford ES, DeBakey ME. Development of artificial intrathoracic circulatory pumps. Am J Surg 1964; 108:685-92.

DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol 1971; 27(1): 3−11.

Tang DG, Oyer PE, Mallidi HR. Ventricular assist devices: history, patient selection, and timing of therapy. J Cardiovasc Transl Res 2009; 2(2): 159−67.

Krishnamani R, DeNofrio D, Konstam MA. Emerging ventricular assist devices for long-term cardiac support. Nat Rev Cardiol 2010; 7(2) :71−6.

Lahpor JR. State of the art: implantable ventricular assist devices. Curr Opin Organ Transplant 2009; 14(5): 554−9.

Wilson SR, Givertz MM, Stewart GC, Mudge GH Jr. Ventricular assist devices the challenges of outpatient management. J Am Coll Cardiol 2009; 54(18):1647-1659.

Nose Y. Design and development strategy for the rotary blood pump. Artif Organs 1998; 22(6): 438−46.

Zhang Y, Zhan Z, Gui XM, Sun HS, Zhang H, Zheng Z, et al. Design optimization of an axial blood pump with computational fluid dynamics. ASAIO J 2008; 54(2): 150−5.

Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010; 29(1): 1−10.

Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010; 55(17): 1826−34.

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361(23): 2241−51.

Rector TS, Taylor BC, Greer N, Rutks I, Wilt TJ. Use of Left Ventricular Assist Devices as Destination Therapy in End-Stage Congestive Heart Failure: A Systematic Review. Washington (DC): Department of Veterans Affairs; 2012.

Slaughter MS. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg 2010; 25(4): 490−4.

Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996; 62(3): 675−81.

Radovancevic B, Vrtovec B, de KE, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant 2007; 26(8): 815−8.

Sansone F, Zingarelli E, Flocco R, Dato GM, Parisi F, Punta G, et al. Pulsed or continuous flow in long-term assist devices: a debated topic. Transplant Rev (Orlando) 2012; 26(4): 241−5.

Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 2004; 77(1): 133−42.

Frazier OH, Gemmato C, Myers TJ, Gregoric ID, Radovancevic B, Loyalka P, et al. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J 2007; 34(3): 275−81.

Sheikh FH, Russell SD. HeartMate(R) II continuous-flow left ventricular assist system. Expert Rev Med Devices 2011; 8(1): 11−21.

Milla F, Pinney SP, Anyanwu AC. Indications for heart transplantation in current era of left ventricular assist devices. Mt Sinai J Med 2012; 79(3): 305−16.

Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357(9): 885−96.

Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57(19): 1890−8.

Patel CB, Rogers JG. Durable mechanical circulatory support devices. Prog Cardiovasc Dis 2011; 54(2):132−43.

Slaughter MS, Sobieski MA, Tamez D, Horrell T, Graham J, Pappas PS, et al. HeartWare miniature axial-flow ventricular assist device: design and initial feasibility test. Tex Heart Inst J 2009; 36(1): 12−6.

Slaughter MS. Implantation of the HeartWare left ventricular assist device. Semin Thorac Cardiovasc Surg 2011; 23(3): 245−7.

Tuzun E, Roberts K, Cohn WE, Sargin M, Gemmato CJ, Radovancevic B, et al. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J 2007; 34(4): 406−11.

Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 2010; 56(4): 285−9.

Wieselthaler GM, Driscoll O, Jansz P, Khaghani A, Strueber M. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010; 29(11): 1218−25.

Strueber M, Meyer AL, Malehsa D, Haverich A. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg 2010; 140(4): 936−7.

Potapov EV, Stepanenko A, Krabatsch T, Hetzer R. Managing long-term complications of left ventricular assist device therapy. Curr Opin Cardiol 2011; 26(3): 237−44.

Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant 2009; 28(9): 881−7.

Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 2010; 29(4 Suppl): S1−39.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 2008; 86(4): 1227−34.

Bhamidipati CM, Ailawadi G, Bergin J, Kern JA. Early thrombus in a HeartMate II left ventricular assist device: a potential cause of hemolysis and diagnostic dilemma. J Thorac Cardiovasc Surg 2010; 140(1): e7−8.

Meyer AL, Kuehn C, Weidemann J, Malehsa D, Bara C, Fischer S, et al. Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 2008; 135(1): 203−4.

Califano S, Pagani FD, Malani PN. Left ventricular assist device-associated infections. Infect Dis Clin North Am 2012; 26(1): 77−87.

Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 1997; 16(8): 822−31.

Bentz B, Hupcey JE, Polomano RC, Boehmer JP. A retrospective study of left ventricular assist device-related infections. J Cardiovasc Manag 2004; 15(1): 9−16.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. J Thorac Cardiovasc Surg 2010; 140(1): 174−81.

Akay MH, Gregoric I, Cohn WE, Frazier OH. HeartMate-II Left Ventricular Assist Device Infections Resulting from Gastrointestinal-Tract Fistulas. J Card Surg 2012; 27(5): 643−5.

Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ Heart Fail 2010; 3(6): 668−74.

Mudd JO, Cuda JD, Halushka M, Soderlund KA, Conte JV, Russell SD. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant 2008; 27(12): 1269−74.

Jafar M, Gregoric ID, Radovancevic R, Cohn WE, McGuire N, Frazier OH. Urgent exchange of a HeartMate II left ventricular assist device after percutaneous lead fracture. ASAIO J 2009; 55(5): 523−4.

Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 2004; 23(8): 964−9.

Pelenghi S, Colombo T, Montorsi E, Newcomb A, Frigerio M, Martinelli L. Failure and off-pump replacement of Incor LVAD system. ASAIO J 2009; 55(1): 121−2.